Page last updated: 2024-08-25

bromopyruvate and daunorubicin

bromopyruvate has been researched along with daunorubicin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhatt, AN; Kalra, N; Kumari, N; Rai, Y; Yadav, P	1

Other Studies

1 other study(ies) available for bromopyruvate and daunorubicin

Article	Year
Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin. Bioscience reports, 2019, 09-30, Volume: 39, Issue:9 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Daunorubicin; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glucose; Hexokinase; Humans; Leukemia, Myeloid; Mitochondria; Pyruvates; Reactive Oxygen Species	2019

Article

Year

Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin.

Bioscience reports, 2019, 09-30, Volume: 39, Issue:9

Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Daunorubicin; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glucose; Hexokinase; Humans; Leukemia, Myeloid; Mitochondria; Pyruvates; Reactive Oxygen Species

2019